Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
Introduction: The pathological progression of non-alcoholic fatty liver disease (NAFLD) is driven by multiple factors, and non-alcoholic steatohepatitis (NASH) represents its progressive form. In our previous studies, we found that bicyclol had beneficial effects on NAFLD/ NASH. Here we aim to inves...
Saved in:
Main Authors: | Jingyi Wu (Author), Shu Jia (Author), Benhong Xu (Author), Xiaokun Yao (Author), Jingping Shao (Author), Jianzuo Yao (Author), Danwei Cen (Author), Xiaomin Yao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
by: Frontiers Production Office
Published: (2023) -
Is non-alcoholic steatohepatitis caused by alcohol?
by: Hubert E Blum
Published: (2020) -
Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Tharani Senavirathna, et al.
Published: (2024) -
Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
by: Hongxue Li, et al.
Published: (2021) -
Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
by: Rosa Lombardi, et al.
Published: (2021)